These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 21229608
1. 5,7,3'-Trihydroxy-3,4'-dimethoxyflavone inhibits the tubulin polymerization and activates the sphingomyelin pathway. Torres F, Quintana J, Estévez F. Mol Carcinog; 2011 Feb; 50(2):113-22. PubMed ID: 21229608 [Abstract] [Full Text] [Related]
2. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC, Chung JG. J Pharmacol Exp Ther; 2010 Aug; 334(2):477-88. PubMed ID: 20463006 [Abstract] [Full Text] [Related]
3. Betuletol 3-methyl ether induces G(2)-M phase arrest and activates the sphingomyelin and MAPK pathways in human leukemia cells. Rubio S, Quintana J, Eiroa JL, Triana J, Estévez F. Mol Carcinog; 2010 Jan; 49(1):32-43. PubMed ID: 19676104 [Abstract] [Full Text] [Related]
4. BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY. Cancer Res; 2004 Jul 01; 64(13):4621-8. PubMed ID: 15231674 [Abstract] [Full Text] [Related]
5. Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways. Chen YC, Lu PH, Pan SL, Teng CM, Kuo SC, Lin TP, Ho YF, Huang YC, Guh JH. Biochem Pharmacol; 2007 Jun 30; 74(1):10-9. PubMed ID: 17475221 [Abstract] [Full Text] [Related]
6. 5,7,3'-trihydroxy-3,4'-dimethoxyflavone-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway. Torres F, Quintana J, Estévez F. Mol Carcinog; 2010 May 30; 49(5):464-75. PubMed ID: 20175127 [Abstract] [Full Text] [Related]
7. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. Chang HL, Wu YC, Su JH, Yeh YT, Yuan SS. J Pharmacol Exp Ther; 2008 Jun 30; 325(3):841-9. PubMed ID: 18337475 [Abstract] [Full Text] [Related]
8. Induction of tubulin polymerization and apoptosis in malignant mesothelioma cells by a new compound JBIR-23. Hwang JH, Takagi M, Murakami H, Sekido Y, Shin-ya K. Cancer Lett; 2011 Jan 28; 300(2):189-96. PubMed ID: 21055871 [Abstract] [Full Text] [Related]
9. Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways. Ray G, Dhar G, Van Veldhuizen PJ, Banerjee S, Saxena NK, Sengupta K, Banerjee SK. Biochemistry; 2006 Mar 21; 45(11):3703-13. PubMed ID: 16533053 [Abstract] [Full Text] [Related]
10. Double blockade of cell cycle at g(1)-s transition and m phase by 3-iodoacetamido benzoyl ethyl ester, a new type of tubulin ligand. Jiang JD, Denner L, Ling YH, Li JN, Davis A, Wang Y, Li Y, Roboz J, Wang LG, Perez-Soler R, Marcelli M, Bekesi G, Holland JF. Cancer Res; 2002 Nov 01; 62(21):6080-8. PubMed ID: 12414632 [Abstract] [Full Text] [Related]
11. Induction of G2/M phase arrest and apoptosis by the flavonoid tamarixetin on human leukemia cells. Nicolini F, Burmistrova O, Marrero MT, Torres F, Hernández C, Quintana J, Estévez F. Mol Carcinog; 2014 Dec 01; 53(12):939-50. PubMed ID: 23765509 [Abstract] [Full Text] [Related]
12. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity. Zhang LH, Wu L, Raymon HK, Chen RS, Corral L, Shirley MA, Narla RK, Gamez J, Muller GW, Stirling DI, Bartlett JB, Schafer PH, Payvandi F. Cancer Res; 2006 Jan 15; 66(2):951-9. PubMed ID: 16424030 [Abstract] [Full Text] [Related]
13. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule. Liou JP, Hsu KS, Kuo CC, Chang CY, Chang JY. J Pharmacol Exp Ther; 2007 Oct 15; 323(1):398-405. PubMed ID: 17660383 [Abstract] [Full Text] [Related]
14. Physalis angulata induced G2/M phase arrest in human breast cancer cells. Hsieh WT, Huang KY, Lin HY, Chung JG. Food Chem Toxicol; 2006 Jul 15; 44(7):974-83. PubMed ID: 16427178 [Abstract] [Full Text] [Related]
15. Protoapigenone, a novel flavonoid, inhibits ovarian cancer cell growth in vitro and in vivo. Chang HL, Su JH, Yeh YT, Lee YC, Chen HM, Wu YC, Yuan SS. Cancer Lett; 2008 Aug 18; 267(1):85-95. PubMed ID: 18430509 [Abstract] [Full Text] [Related]
16. Acetyl derivative of quercetin 3-methyl ether-induced cell death in human leukemia cells is amplified by the inhibition of ERK. Rubio S, Quintana J, Eiroa JL, Triana J, Estévez F. Carcinogenesis; 2007 Oct 18; 28(10):2105-13. PubMed ID: 17548901 [Abstract] [Full Text] [Related]
17. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo. Hsu YL, Kuo PL, Tzeng TF, Sung SC, Yen MH, Lin LT, Lin CC. J Gastroenterol Hepatol; 2008 Jul 18; 23(7 Pt 2):e290-9. PubMed ID: 18522681 [Abstract] [Full Text] [Related]
18. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle. Lin CC, Lin SY, Chung JG, Lin JP, Chen GW, Kao ST. Anticancer Res; 2006 Jul 18; 26(2A):1097-104. PubMed ID: 16619512 [Abstract] [Full Text] [Related]
19. In vitro and in vivo studies of a novel potential anticancer agent of isochaihulactone on human lung cancer A549 cells. Chen YL, Lin SZ, Chang JY, Cheng YL, Tsai NM, Chen SP, Chang WL, Harn HJ. Biochem Pharmacol; 2006 Jul 28; 72(3):308-19. PubMed ID: 16782069 [Abstract] [Full Text] [Related]
20. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Shin SW, Seo CY, Han H, Han JY, Jeong JS, Kwak JY, Park JI. Clin Cancer Res; 2009 Sep 01; 15(17):5414-25. PubMed ID: 19690198 [Abstract] [Full Text] [Related] Page: [Next] [New Search]